AcquisitionOther
Coherus BioSciences, Inc. acquired Ophthalmology Franchise
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Coherus BioSciences, Inc. -> Ophthalmology Franchise · $170 million
“This transaction sharpens the focus of our business as we advance our novel immuno-oncology pipeline and continue the launch of LOQTORZI ™ in nasopharyngeal carcinoma and UDENYCA® ONBODY ™ ,” said Denny Lanfear, Chairman and Chief Executive Officer of Coher
Open source record (SEC) ↗